These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 16736050)

  • 1. In vivo quantification of serotonin transporters using [(11)C]DASB and positron emission tomography in humans: modeling considerations.
    Ogden RT; Ojha A; Erlandsson K; Oquendo MA; Mann JJ; Parsey RV
    J Cereb Blood Flow Metab; 2007 Jan; 27(1):205-17. PubMed ID: 16736050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PET imaging of serotonin transporters with [11C]DASB: test-retest reproducibility using a multilinear reference tissue parametric imaging method.
    Kim JS; Ichise M; Sangare J; Innis RB
    J Nucl Med; 2006 Feb; 47(2):208-14. PubMed ID: 16455625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling considerations for 11C-CUMI-101, an agonist radiotracer for imaging serotonin 1A receptor in vivo with PET.
    Milak MS; Severance AJ; Ogden RT; Prabhakaran J; Kumar JS; Majo VJ; Mann JJ; Parsey RV
    J Nucl Med; 2008 Apr; 49(4):587-96. PubMed ID: 18344443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of preprocessing strategies in Positron Emission Tomography (PET) neuroimaging: A [
    Nørgaard M; Ganz M; Svarer C; Frokjaer VG; Greve DN; Strother SC; Knudsen GM
    Neuroimage; 2019 Oct; 199():466-479. PubMed ID: 31158479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of serotonin transporter parameters with 11C-DASB in healthy humans: reproducibility and comparison of methods.
    Frankle WG; Slifstein M; Gunn RN; Huang Y; Hwang DR; Darr EA; Narendran R; Abi-Dargham A; Laruelle M
    J Nucl Med; 2006 May; 47(5):815-26. PubMed ID: 16644752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolite considerations in the in vivo quantification of serotonin transporters using 11C-DASB and PET in humans.
    Parsey RV; Ojha A; Ogden RT; Erlandsson K; Kumar D; Landgrebe M; Van Heertum R; Mann JJ
    J Nucl Med; 2006 Nov; 47(11):1796-802. PubMed ID: 17079812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced serotonin transporter binding in the insular cortex in patients with obsessive-compulsive disorder: a [11C]DASB PET study.
    Matsumoto R; Ichise M; Ito H; Ando T; Takahashi H; Ikoma Y; Kosaka J; Arakawa R; Fujimura Y; Ota M; Takano A; Fukui K; Nakayama K; Suhara T
    Neuroimage; 2010 Jan; 49(1):121-6. PubMed ID: 19660554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positron emission tomography quantification of [(11)C]-DASB binding to the human serotonin transporter: modeling strategies.
    Ginovart N; Wilson AA; Meyer JH; Hussey D; Houle S
    J Cereb Blood Flow Metab; 2001 Nov; 21(11):1342-53. PubMed ID: 11702049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin transporter binding in bipolar disorder assessed using [11C]DASB and positron emission tomography.
    Cannon DM; Ichise M; Fromm SJ; Nugent AC; Rollis D; Gandhi SK; Klaver JM; Charney DS; Manji HK; Drevets WC
    Biol Psychiatry; 2006 Aug; 60(3):207-17. PubMed ID: 16875929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo quantification of human serotonin 1A receptor using 11C-CUMI-101, an agonist PET radiotracer.
    Milak MS; DeLorenzo C; Zanderigo F; Prabhakaran J; Kumar JS; Majo VJ; Mann JJ; Parsey RV
    J Nucl Med; 2010 Dec; 51(12):1892-900. PubMed ID: 21098796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantifying serotonin transporters by PET with [11C]-DASB before and after interferon-α treatment.
    Shapiro PA; Sloan RP; Deochand C; Franceschi AM; Delorenzo C; Mann JJ; Parsey RV
    Synapse; 2014 Nov; 68(11):548-55. PubMed ID: 25043294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin transporter availability in patients with schizophrenia: a positron emission tomography imaging study with [11C]DASB.
    Frankle WG; Narendran R; Huang Y; Hwang DR; Lombardo I; Cangiano C; Gil R; Laruelle M; Abi-Dargham A
    Biol Psychiatry; 2005 Jun; 57(12):1510-6. PubMed ID: 15953487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positron emission tomography quantification of serotonin transporter binding in medication-free bipolar disorder.
    Miller JM; Everett BA; Oquendo MA; Ogden RT; Mann JJ; Parsey RV
    Synapse; 2016 Jan; 70(1):24-32. PubMed ID: 26426356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of ligand PET studies using a reference region with a displaceable fraction: application to occupancy studies with [(11)C]-DASB as an example.
    Turkheimer FE; Selvaraj S; Hinz R; Murthy V; Bhagwagar Z; Grasby P; Howes O; Rosso L; Bose SK
    J Cereb Blood Flow Metab; 2012 Jan; 32(1):70-80. PubMed ID: 21811290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated serotonin transporter binding in major depressive disorder assessed using positron emission tomography and [11C]DASB; comparison with bipolar disorder.
    Cannon DM; Ichise M; Rollis D; Klaver JM; Gandhi SK; Charney DS; Manji HK; Drevets WC
    Biol Psychiatry; 2007 Oct; 62(8):870-7. PubMed ID: 17678634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of reduced endogenous 5-HT on the in vivo binding of the serotonin transporter radioligand 11C-DASB in healthy humans.
    Talbot PS; Frankle WG; Hwang DR; Huang Y; Suckow RF; Slifstein M; Abi-Dargham A; Laruelle M
    Synapse; 2005 Mar; 55(3):164-75. PubMed ID: 15605360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ecstasy-induced reduction of the availability of the brain serotonin transporter as revealed by [11C](+)McN5652-PET and the multi-linear reference tissue model: loss of transporters or artifact of tracer kinetic modelling?
    Buchert R; Thiele F; Thomasius R; Wilke F; Petersen K; Brenner W; Mester J; Spies L; Clausen M
    J Psychopharmacol; 2007 Aug; 21(6):628-34. PubMed ID: 17092972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simple and rapid quantification of serotonin transporter binding using [
    Gryglewski G; Rischka L; Philippe C; Hahn A; James GM; Klebermass E; Hienert M; Silberbauer L; Vanicek T; Kautzky A; Berroterán-Infante N; Nics L; Traub-Weidinger T; Mitterhauser M; Wadsak W; Hacker M; Kasper S; Lanzenberger R
    Neuroimage; 2017 Apr; 149():23-32. PubMed ID: 28119137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tracer kinetic modeling of [(11)C]AFM, a new PET imaging agent for the serotonin transporter.
    Naganawa M; Nabulsi N; Planeta B; Gallezot JD; Lin SF; Najafzadeh S; Williams W; Ropchan J; Labaree D; Neumeister A; Huang Y; Carson RE
    J Cereb Blood Flow Metab; 2013 Dec; 33(12):1886-96. PubMed ID: 23921898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central serotonin transporter availability in highly obese individuals compared with non-obese controls: A [(11)C] DASB positron emission tomography study.
    Hesse S; Rullmann M; Luthardt J; Winter K; Hankir MK; Becker GA; Zientek F; Reissig G; Regenthal R; Drabe M; Schinke C; Bresch A; Arelin K; Lobsien D; Patt M; Meyer PM; Fasshauer M; Fenske WK; Blüher M; Stumvoll M; Sabri O
    Eur J Nucl Med Mol Imaging; 2016 Jun; 43(6):1096-104. PubMed ID: 26577939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.